Savara (SVRA) Preferred Shares Issued (2011 - 2016)

Savara (SVRA) reported Preferred Shares Issued of $6000.0 for Q3 2016, down 99.97% quarter-over-quarter from $22.5 million in Q1 2011.

Savara (SVRA) Preferred Shares Issued (2011 - 2016) Analysis & Trends

Savara (SVRA) has 2 years of Preferred Shares Issued data on file, last reported at $6000.0 in Q3 2016.

Preferred Shares Issued for Q3 2016 came in at $6000.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2016 was $22.5 million (changed N/A YoY), and the FY2016 annual result was $782000.0, down 91.09% from the prior year.
Preferred Shares Issued fell to $6000.0 in Q3 2016 per SVRA's latest filing, from $22.5 million in the prior quarter.
Over five years, Preferred Shares Issued peaked at $6000.0 in Q3 2016 and troughed at $6000.0 in Q3 2016.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Preferred Shares Issued (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn	-
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-	-
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-	-
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn	-
9	Abivax	91.96 Bn	91.96 Bn	-	-
10	Savara	1.39 Bn	1.39 Bn	-	-

Download Data